Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 11, 2023

SELL
$0.0 - $137.11 $0 - $9,597
-70 Reduced 0.58%
11,945 $0
Q1 2023

Apr 11, 2023

BUY
$120.16 - $144.38 $444,592 - $534,206
3,700 Added 44.5%
12,015 $1.6 Million
Q4 2022

Jan 13, 2023

SELL
$119.0 - $147.98 $104,720 - $130,222
-880 Reduced 9.57%
8,315 $0
Q3 2022

Oct 11, 2022

SELL
$118.07 - $160.96 $148,768 - $202,809
-1,260 Reduced 12.05%
9,195 $1.11 Million
Q2 2022

Jul 11, 2022

SELL
$134.91 - $172.49 $193,865 - $247,868
-1,437 Reduced 12.08%
10,455 $1.49 Million
Q1 2022

Apr 11, 2022

SELL
$162.31 - $192.2 $162,310 - $192,200
-1,000 Reduced 7.76%
11,892 $2.08 Million
Q4 2021

Jan 19, 2022

BUY
$166.66 - $201.06 $74,497 - $89,873
447 Added 3.59%
12,892 $2.59 Million
Q3 2021

Nov 01, 2021

BUY
$151.98 - $190.5 $118,544 - $148,590
780 Added 6.69%
12,445 $2.16 Million
Q2 2021

Jul 26, 2021

SELL
$127.81 - $155.84 $23,005 - $28,051
-180 Reduced 1.52%
11,665 $1.8 Million
Q1 2021

May 10, 2021

BUY
$120.35 - $160.53 $518,708 - $691,884
4,310 Added 57.2%
11,845 $1.52 Million
Q4 2020

Feb 02, 2021

BUY
$122.05 - $147.91 $46,379 - $56,205
380 Added 5.31%
7,535 $1.08 Million
Q3 2020

Nov 12, 2020

BUY
$97.09 - $125.51 $6,310 - $8,158
65 Added 0.92%
7,155 $898,000
Q2 2020

Jul 29, 2020

SELL
$70.83 - $105.31 $15,582 - $23,168
-220 Reduced 3.01%
7,090 $695,000
Q1 2020

May 08, 2020

SELL
$66.71 - $101.73 $50,699 - $77,314
-760 Reduced 9.42%
7,310 $550,000
Q3 2018

Nov 20, 2019

SELL
$72.59 - $97.27 $174,216 - $233,448
-2,400 Reduced 22.92%
8,070 $710,000
Q2 2018

Nov 14, 2019

BUY
$72.1 - $79.39 $6,488 - $7,145
90 Added 0.87%
10,470 $790,000
Q1 2018

Nov 14, 2019

SELL
$72.06 - $82.75 $53,324 - $61,235
-740 Reduced 6.65%
10,380 $761,000
Q4 2017

Nov 19, 2019

BUY
$69.36 - $73.84 $771,283 - $821,100
11,120
11,120 $875,000

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Orser Capital Management, LLC Portfolio

Follow Orser Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orser Capital Management, LLC with notifications on news.